Used in pharmaceutical research as an intermediate in the synthesis of biologically active compounds, particularly those targeting central nervous system disorders. Its structure supports the development of novel agents with potential antipsychotic or antidepressant effects. The presence of trifluoromethyl and benzyl groups enhances metabolic stability and receptor binding affinity, making it valuable in medicinal chemistry for optimizing drug candidates. Also employed in structure-activity relationship (SAR) studies to explore potency and selectivity in new therapeutic molecules.